[23] Targeted delivery of antisense oligonucleotides to parenchymal liver cells in vivo
Oligodeoxynucleotides (ODNs) inhibit gene expression at various levels both in vitro and in vivo. In vivo, the efficacy of ODN-induced regulation of genes in specific cell types may be suboptimal owing to poor accumulation of ODNs in these cells. In addition, untimely elimination of ODNs through ren...
Gespeichert in:
Veröffentlicht in: | Methods in Enzymology 2000, Vol.314, p.324-342 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 342 |
---|---|
container_issue | |
container_start_page | 324 |
container_title | Methods in Enzymology |
container_volume | 314 |
creator | Biessen, E.A.L. Vietsch, H. Rump, E.T. Fluiter, K. Busterbosch, M.K. van Berkel, T.J.C. |
description | Oligodeoxynucleotides (ODNs) inhibit gene expression at various levels both in vitro and in vivo. In vivo, the efficacy of ODN-induced regulation of genes in specific cell types may be suboptimal owing to poor accumulation of ODNs in these cells. In addition, untimely elimination of ODNs through renal clearance, degradation, and scavenger receptor-mediated uptake may further impair their therapeutic activity. These hurdles can be at least partly overcome by targeted delivery of the ODNs to the desired site of action. As short (and in particular uncharged) oligothymidinylates are poor substrates for hepatic scavenger receptors that are responsible for the rapid elimination of ODNs by cells of the reticuloendothelial system, the results leave unanswered whether longer, charged, and miscellaneous ODN sequences can also be redirected to the aimed target cell in vivo. In this respect, it is crucial to analyze the tissue distribution and identify the cellular uptake sites within the liver, using full-length antisense sequences. In the study described in the chapter, in vivo evidence is provided that untimely elimination of a miscellaneous 20-mer ODN by the preceding scavenger pathways can be circumvented and, concomitantly, accumulation by parenchymal liver cells can be enhanced after derivatization with a small-sized synthetic galactoside with high affinity for the asialoglycoprotein receptor. |
doi_str_mv | 10.1016/S0076-6879(99)14113-2 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_70799091</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0076687999141132</els_id><sourcerecordid>70799091</sourcerecordid><originalsourceid>FETCH-LOGICAL-c315t-c66e6069e2582caf1e23466a241de8a3e0829a60e7f32ac63a923d55abab7adf3</originalsourceid><addsrcrecordid>eNo9kUtLAzEUhYMPtNb-BCUr0cVoHs1rJSK-QHBhxYVISJM7NTKd1Mm00H_v9KGru_nO4dxzEDqh5JISKq9eCVGykFqZc2Mu6JBSXrAd1KNCqEIZrXfRwChNKKOaMSrkHur9Sw7RUc7fhDClDT1Ah5QIKQjjPfT-wfgnHrlmAi0EHKCKC2iWOJXY1W3MUGfAqYqTVM99BamNATJuE565Bmr_tZy6Cq812ENVZRxrvIiLdIz2S1dlGGxvH73d341uH4vnl4en25vnwnMq2sJLCZJIA0xo5l1JgfGhlI4NaQDtOBDNjJMEVMmZ85I7w3gQwo3dWLlQ8j462_jOmvQzh9zaacyrJK6GNM9WEWUMMbQDT7fgfDyFYGdNnLpmaf-q6IDrDQBd3EWExmYfuxchxAZ8a0OKHWxXY9j1GHbVrDXGrsewjP8CaqJ5Mw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70799091</pqid></control><display><type>article</type><title>[23] Targeted delivery of antisense oligonucleotides to parenchymal liver cells in vivo</title><source>MEDLINE</source><source>ScienceDirect eBooks</source><source>Access via ScienceDirect (Elsevier)</source><creator>Biessen, E.A.L. ; Vietsch, H. ; Rump, E.T. ; Fluiter, K. ; Busterbosch, M.K. ; van Berkel, T.J.C.</creator><creatorcontrib>Biessen, E.A.L. ; Vietsch, H. ; Rump, E.T. ; Fluiter, K. ; Busterbosch, M.K. ; van Berkel, T.J.C.</creatorcontrib><description>Oligodeoxynucleotides (ODNs) inhibit gene expression at various levels both in vitro and in vivo. In vivo, the efficacy of ODN-induced regulation of genes in specific cell types may be suboptimal owing to poor accumulation of ODNs in these cells. In addition, untimely elimination of ODNs through renal clearance, degradation, and scavenger receptor-mediated uptake may further impair their therapeutic activity. These hurdles can be at least partly overcome by targeted delivery of the ODNs to the desired site of action. As short (and in particular uncharged) oligothymidinylates are poor substrates for hepatic scavenger receptors that are responsible for the rapid elimination of ODNs by cells of the reticuloendothelial system, the results leave unanswered whether longer, charged, and miscellaneous ODN sequences can also be redirected to the aimed target cell in vivo. In this respect, it is crucial to analyze the tissue distribution and identify the cellular uptake sites within the liver, using full-length antisense sequences. In the study described in the chapter, in vivo evidence is provided that untimely elimination of a miscellaneous 20-mer ODN by the preceding scavenger pathways can be circumvented and, concomitantly, accumulation by parenchymal liver cells can be enhanced after derivatization with a small-sized synthetic galactoside with high affinity for the asialoglycoprotein receptor.</description><identifier>ISSN: 0076-6879</identifier><identifier>ISBN: 9780121822156</identifier><identifier>ISBN: 012182215X</identifier><identifier>EISSN: 1557-7988</identifier><identifier>DOI: 10.1016/S0076-6879(99)14113-2</identifier><identifier>PMID: 10565023</identifier><language>eng</language><publisher>United States: Elsevier Science & Technology</publisher><subject>Animals ; Asialoglycoproteins - metabolism ; Biological Availability ; Drug Carriers ; Drug Delivery Systems - methods ; Drug Stability ; Glycopeptides ; Liver - cytology ; Liver - drug effects ; Membrane Proteins ; Oligodeoxyribonucleotides, Antisense - administration & dosage ; Oligodeoxyribonucleotides, Antisense - chemistry ; Oligodeoxyribonucleotides, Antisense - pharmacokinetics ; Orosomucoid - metabolism ; Rats ; Receptors, Immunologic - metabolism ; Receptors, Lipoprotein ; Receptors, Scavenger ; Scavenger Receptors, Class B</subject><ispartof>Methods in Enzymology, 2000, Vol.314, p.324-342</ispartof><rights>2000</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c315t-c66e6069e2582caf1e23466a241de8a3e0829a60e7f32ac63a923d55abab7adf3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0076687999141132$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>315,780,781,785,794,3460,3551,4025,11293,27928,27929,27930,45815,46000</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10565023$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Biessen, E.A.L.</creatorcontrib><creatorcontrib>Vietsch, H.</creatorcontrib><creatorcontrib>Rump, E.T.</creatorcontrib><creatorcontrib>Fluiter, K.</creatorcontrib><creatorcontrib>Busterbosch, M.K.</creatorcontrib><creatorcontrib>van Berkel, T.J.C.</creatorcontrib><title>[23] Targeted delivery of antisense oligonucleotides to parenchymal liver cells in vivo</title><title>Methods in Enzymology</title><addtitle>Methods Enzymol</addtitle><description>Oligodeoxynucleotides (ODNs) inhibit gene expression at various levels both in vitro and in vivo. In vivo, the efficacy of ODN-induced regulation of genes in specific cell types may be suboptimal owing to poor accumulation of ODNs in these cells. In addition, untimely elimination of ODNs through renal clearance, degradation, and scavenger receptor-mediated uptake may further impair their therapeutic activity. These hurdles can be at least partly overcome by targeted delivery of the ODNs to the desired site of action. As short (and in particular uncharged) oligothymidinylates are poor substrates for hepatic scavenger receptors that are responsible for the rapid elimination of ODNs by cells of the reticuloendothelial system, the results leave unanswered whether longer, charged, and miscellaneous ODN sequences can also be redirected to the aimed target cell in vivo. In this respect, it is crucial to analyze the tissue distribution and identify the cellular uptake sites within the liver, using full-length antisense sequences. In the study described in the chapter, in vivo evidence is provided that untimely elimination of a miscellaneous 20-mer ODN by the preceding scavenger pathways can be circumvented and, concomitantly, accumulation by parenchymal liver cells can be enhanced after derivatization with a small-sized synthetic galactoside with high affinity for the asialoglycoprotein receptor.</description><subject>Animals</subject><subject>Asialoglycoproteins - metabolism</subject><subject>Biological Availability</subject><subject>Drug Carriers</subject><subject>Drug Delivery Systems - methods</subject><subject>Drug Stability</subject><subject>Glycopeptides</subject><subject>Liver - cytology</subject><subject>Liver - drug effects</subject><subject>Membrane Proteins</subject><subject>Oligodeoxyribonucleotides, Antisense - administration & dosage</subject><subject>Oligodeoxyribonucleotides, Antisense - chemistry</subject><subject>Oligodeoxyribonucleotides, Antisense - pharmacokinetics</subject><subject>Orosomucoid - metabolism</subject><subject>Rats</subject><subject>Receptors, Immunologic - metabolism</subject><subject>Receptors, Lipoprotein</subject><subject>Receptors, Scavenger</subject><subject>Scavenger Receptors, Class B</subject><issn>0076-6879</issn><issn>1557-7988</issn><isbn>9780121822156</isbn><isbn>012182215X</isbn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kUtLAzEUhYMPtNb-BCUr0cVoHs1rJSK-QHBhxYVISJM7NTKd1Mm00H_v9KGru_nO4dxzEDqh5JISKq9eCVGykFqZc2Mu6JBSXrAd1KNCqEIZrXfRwChNKKOaMSrkHur9Sw7RUc7fhDClDT1Ah5QIKQjjPfT-wfgnHrlmAi0EHKCKC2iWOJXY1W3MUGfAqYqTVM99BamNATJuE565Bmr_tZy6Cq812ENVZRxrvIiLdIz2S1dlGGxvH73d341uH4vnl4en25vnwnMq2sJLCZJIA0xo5l1JgfGhlI4NaQDtOBDNjJMEVMmZ85I7w3gQwo3dWLlQ8j462_jOmvQzh9zaacyrJK6GNM9WEWUMMbQDT7fgfDyFYGdNnLpmaf-q6IDrDQBd3EWExmYfuxchxAZ8a0OKHWxXY9j1GHbVrDXGrsewjP8CaqJ5Mw</recordid><startdate>2000</startdate><enddate>2000</enddate><creator>Biessen, E.A.L.</creator><creator>Vietsch, H.</creator><creator>Rump, E.T.</creator><creator>Fluiter, K.</creator><creator>Busterbosch, M.K.</creator><creator>van Berkel, T.J.C.</creator><general>Elsevier Science & Technology</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>2000</creationdate><title>[23] Targeted delivery of antisense oligonucleotides to parenchymal liver cells in vivo</title><author>Biessen, E.A.L. ; Vietsch, H. ; Rump, E.T. ; Fluiter, K. ; Busterbosch, M.K. ; van Berkel, T.J.C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c315t-c66e6069e2582caf1e23466a241de8a3e0829a60e7f32ac63a923d55abab7adf3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Animals</topic><topic>Asialoglycoproteins - metabolism</topic><topic>Biological Availability</topic><topic>Drug Carriers</topic><topic>Drug Delivery Systems - methods</topic><topic>Drug Stability</topic><topic>Glycopeptides</topic><topic>Liver - cytology</topic><topic>Liver - drug effects</topic><topic>Membrane Proteins</topic><topic>Oligodeoxyribonucleotides, Antisense - administration & dosage</topic><topic>Oligodeoxyribonucleotides, Antisense - chemistry</topic><topic>Oligodeoxyribonucleotides, Antisense - pharmacokinetics</topic><topic>Orosomucoid - metabolism</topic><topic>Rats</topic><topic>Receptors, Immunologic - metabolism</topic><topic>Receptors, Lipoprotein</topic><topic>Receptors, Scavenger</topic><topic>Scavenger Receptors, Class B</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Biessen, E.A.L.</creatorcontrib><creatorcontrib>Vietsch, H.</creatorcontrib><creatorcontrib>Rump, E.T.</creatorcontrib><creatorcontrib>Fluiter, K.</creatorcontrib><creatorcontrib>Busterbosch, M.K.</creatorcontrib><creatorcontrib>van Berkel, T.J.C.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Methods in Enzymology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Biessen, E.A.L.</au><au>Vietsch, H.</au><au>Rump, E.T.</au><au>Fluiter, K.</au><au>Busterbosch, M.K.</au><au>van Berkel, T.J.C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>[23] Targeted delivery of antisense oligonucleotides to parenchymal liver cells in vivo</atitle><jtitle>Methods in Enzymology</jtitle><addtitle>Methods Enzymol</addtitle><date>2000</date><risdate>2000</risdate><volume>314</volume><spage>324</spage><epage>342</epage><pages>324-342</pages><issn>0076-6879</issn><eissn>1557-7988</eissn><isbn>9780121822156</isbn><isbn>012182215X</isbn><abstract>Oligodeoxynucleotides (ODNs) inhibit gene expression at various levels both in vitro and in vivo. In vivo, the efficacy of ODN-induced regulation of genes in specific cell types may be suboptimal owing to poor accumulation of ODNs in these cells. In addition, untimely elimination of ODNs through renal clearance, degradation, and scavenger receptor-mediated uptake may further impair their therapeutic activity. These hurdles can be at least partly overcome by targeted delivery of the ODNs to the desired site of action. As short (and in particular uncharged) oligothymidinylates are poor substrates for hepatic scavenger receptors that are responsible for the rapid elimination of ODNs by cells of the reticuloendothelial system, the results leave unanswered whether longer, charged, and miscellaneous ODN sequences can also be redirected to the aimed target cell in vivo. In this respect, it is crucial to analyze the tissue distribution and identify the cellular uptake sites within the liver, using full-length antisense sequences. In the study described in the chapter, in vivo evidence is provided that untimely elimination of a miscellaneous 20-mer ODN by the preceding scavenger pathways can be circumvented and, concomitantly, accumulation by parenchymal liver cells can be enhanced after derivatization with a small-sized synthetic galactoside with high affinity for the asialoglycoprotein receptor.</abstract><cop>United States</cop><pub>Elsevier Science & Technology</pub><pmid>10565023</pmid><doi>10.1016/S0076-6879(99)14113-2</doi><tpages>19</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0076-6879 |
ispartof | Methods in Enzymology, 2000, Vol.314, p.324-342 |
issn | 0076-6879 1557-7988 |
language | eng |
recordid | cdi_proquest_miscellaneous_70799091 |
source | MEDLINE; ScienceDirect eBooks; Access via ScienceDirect (Elsevier) |
subjects | Animals Asialoglycoproteins - metabolism Biological Availability Drug Carriers Drug Delivery Systems - methods Drug Stability Glycopeptides Liver - cytology Liver - drug effects Membrane Proteins Oligodeoxyribonucleotides, Antisense - administration & dosage Oligodeoxyribonucleotides, Antisense - chemistry Oligodeoxyribonucleotides, Antisense - pharmacokinetics Orosomucoid - metabolism Rats Receptors, Immunologic - metabolism Receptors, Lipoprotein Receptors, Scavenger Scavenger Receptors, Class B |
title | [23] Targeted delivery of antisense oligonucleotides to parenchymal liver cells in vivo |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-11T19%3A26%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=%5B23%5D%20Targeted%20delivery%20of%20antisense%20oligonucleotides%20to%20parenchymal%20liver%20cells%20in%20vivo&rft.jtitle=Methods%20in%20Enzymology&rft.au=Biessen,%20E.A.L.&rft.date=2000&rft.volume=314&rft.spage=324&rft.epage=342&rft.pages=324-342&rft.issn=0076-6879&rft.eissn=1557-7988&rft.isbn=9780121822156&rft.isbn_list=012182215X&rft_id=info:doi/10.1016/S0076-6879(99)14113-2&rft_dat=%3Cproquest_pubme%3E70799091%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=70799091&rft_id=info:pmid/10565023&rft_els_id=S0076687999141132&rfr_iscdi=true |